In this regard, it is well known that a decreased dosage of Pax5 activity significantly accelerates the development of precursor B-ALL in mice carrying additional fusion genes such as BCR::ABLp190 and ETV6::RUNX1 [29,30]. Here, PAX5 is linked to precursor B-cell acute lymphoblastic leukemia.